{
    "Trade/Device Name(s)": [
        "NIOX\u00ae Panel",
        "NIOX MINO\u00ae Airway Inflammation Monitor"
    ],
    "Submitter Information": "Aerocrine AB",
    "510(k) Number": "K123683",
    "Predicate Device Reference 510(k) Number(s)": [
        "K101034"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MXA"
    ],
    "Summary Letter Date": "November 29, 2012",
    "Summary Letter Received Date": "November 30, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.3080"
    ],
    "Regulation Name(s)": [
        "Breath Nitric Oxide Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "misc"
    ],
    "Analyte(s)": [
        "Nitric Oxide (NO)",
        "Fractional NO concentration in expired breath (FeNO)"
    ],
    "Specimen Type(s)": [
        "Expired human breath"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "NIOX MINO\u00ae Airway Inflammation Monitor",
        "Personal computer (PC) with NIOX\u00ae Panel software"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical detection",
        "Software interface"
    ],
    "Methodologies": [
        "Quantitative measurement",
        "Non-invasive sampling"
    ],
    "Submission Type(s)": [
        "Accessory",
        "Software",
        "Analyzer"
    ],
    "Document Summary": "FDA 510(k) summary for NIOX\u00ae Panel software accessory enabling additional PC display and control of the NIOX MINO\u00ae Airway Inflammation Monitor for breath nitric oxide measurement.",
    "Indications for Use Summary": "Quantitative, non-invasive measurement of nitric oxide in expired breath to monitor asthma patients\u2019 response to anti-inflammatory therapy as an adjunct to established clinical and laboratory assessments; suitable for children ages 7-17 and adults 18+, not for infants or critical care use.",
    "fda_folder": "Toxicology"
}